Correlation Between Terns Pharmaceuticals and Compass Therapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Compass Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Compass Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Compass Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Compass Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Compass Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Compass Therapeutics.
Diversification Opportunities for Terns Pharmaceuticals and Compass Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Terns and Compass is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Compass Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compass Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Compass Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compass Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Compass Therapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Compass Therapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the Compass Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Terns Pharmaceuticals is 1.37 times less risky than Compass Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Compass Therapeutics is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 168.00 in Compass Therapeutics on August 28, 2024 and sell it today you would lose (18.00) from holding Compass Therapeutics or give up 10.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Compass Therapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Compass Therapeutics |
Terns Pharmaceuticals and Compass Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Compass Therapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and Compass Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Compass Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compass Therapeutics will offset losses from the drop in Compass Therapeutics' long position.| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
| Compass Therapeutics vs. Eliem Therapeutics | Compass Therapeutics vs. HCW Biologics | Compass Therapeutics vs. Scpharmaceuticals | Compass Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |